Provention Bio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 174

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.9B

Provention Bio General Information

Description

Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease, including oncological, autoimmune, and inflammatory diseases. The company's product candidates include PRV-031, for the interception, delay, or prevention of type 1 diabetes; PRV-3279, for the potential treatment of systemic lupus erythematosus; and PRV-101.

Contact Information

Formerly Known As
Provention
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 55 Broad Street
  • 2nd Floor
  • Red Bank, NJ 07701
  • United States
+1 (908)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Sanofi
Vertical(s)
Corporate Office
  • 55 Broad Street
  • 2nd Floor
  • Red Bank, NJ 07701
  • United States
+1 (908)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Provention Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Apr-2023 $2.9B Completed Generating Revenue
4. PIPE 04-Aug-2022 Completed Generating Revenue
3. PIPE 24-Sep-2019 Completed Generating Revenue
2. IPO 24-Jul-2018 $65.4M $93.8M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 25-Apr-2017 $28.5M $28.5M Completed Stealth
To view Provention Bio’s complete valuation and funding history, request access »

Provention Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Provention Bio’s complete cap table history, request access »

Provention Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commerciali
Biotechnology
Red Bank, NJ
174 As of 2022

Framingham, MA
 

Basking Ridge, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Provention Bio Competitors (79)

One of Provention Bio’s 79 competitors is Xenetic Bioscience, a Corporation company based in Framingham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xenetic Bioscience Corporation Framingham, MA
Lisata Therapeutics Corporate Backed or Acquired Basking Ridge, NJ
Baliopharm Corporate Backed or Acquired Basel, Switzerland
Incyte Formerly VC-backed Wilmington, DE
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY
You’re viewing 5 of 79 competitors. Get the full list »

Provention Bio Patents

Provention Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230382993-A1 Methods and compositions for preventing or delaying type 1 diabetes Pending 24-May-2022
AU-2023275531-A1 Methods and compositions for preventing or delaying type 1 diabetes Pending 24-May-2022
EP-4532552-A1 Methods and compositions for preventing or delaying type 1 diabetes Pending 24-May-2022
CA-3242085-A1 Methods and compositions for treating barth syndrome Pending 23-Dec-2021
EP-4453040-A2 Methods and compositions for treating barth syndrome Pending 23-Dec-2021 C07K16/283
To view Provention Bio’s complete patent history, request access »

Provention Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Provention Bio Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amgen Corporation Minority
Armistice Capital Hedge Fund Minority
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority
MDB Capital Holdings Investment Bank Minority
Macrogenics Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

Provention Bio Investments (1)

Provention Bio’s most recent deal was a Corporate Asset Purchase with MacroGenics (Anti-CD3 Monoclonal Antibody Teplizumab). The deal was made on 09-May-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MacroGenics (Anti-CD3 Monoclonal Antibody Teplizumab) 09-May-2018 Corporate Asset Purchase Buildings and Property
To view Provention Bio’s complete investments history, request access »

Provention Bio ESG

Risk Overview

Risk Rating

Updated April, 01, 2022

39.58 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,842

Rank

Percentile

Pharmaceuticals

Industry

of 898

Rank

Percentile

Pharmaceuticals

Subindustry

of 428

Rank

Percentile

To view Provention Bio’s complete esg history, request access »

Provention Bio FAQs

  • When was Provention Bio founded?

    Provention Bio was founded in 2016.

  • Where is Provention Bio headquartered?

    Provention Bio is headquartered in Red Bank, NJ.

  • What is the size of Provention Bio?

    Provention Bio has 174 total employees.

  • What industry is Provention Bio in?

    Provention Bio’s primary industry is Biotechnology.

  • Is Provention Bio a private or public company?

    Provention Bio is a Private company.

  • What is the current valuation of Provention Bio?

    The current valuation of Provention Bio is .

  • What is Provention Bio’s current revenue?

    The current revenue for Provention Bio is .

  • How much funding has Provention Bio raised over time?

    Provention Bio has raised $174M.

  • Who are Provention Bio’s investors?

    Amgen, Armistice Capital, Johnson & Johnson Innovation - JJDC, MDB Capital Holdings, and Macrogenics are 5 of 9 investors who have invested in Provention Bio.

  • Who are Provention Bio’s competitors?

    Xenetic Bioscience, Lisata Therapeutics, Baliopharm, Incyte, and Regeneron Pharmaceuticals are some of the 79 competitors of Provention Bio.

  • When was Provention Bio acquired?

    Provention Bio was acquired on 27-Apr-2023.

  • Who acquired Provention Bio?

    Provention Bio was acquired by Sanofi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »